The Introduction of Paxlovid in Canada

Written By Guest User

Dr. Samir Gupta, Respirologist and Associate Professor in the Department of Medicine at the University of Toronto, discusses the introduction of Paxlovid in Canada, and what concerns he has over who the drug was tested on and who will end up using it.

View the segment here

Guest User
Previous

Omricon Sub-variant Growth, Paxlovid Updates & CBD Research
Next

COVID-19 in Quebec: The Proposed Quebec Tax